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Abstract
The key determinant to a fetus maintaining its health is through adequate per-
fusion and oxygen transfer mediated by the functioning placenta. When this
equilibrium is distorted, a number of physiological changes, including reduced
fetal growth, occur to favor survival. Technologies have been developed to
monitor these changes with a view to prolong intrauterine maturity while
reducing the risks of stillbirth. Many of these strategies involve complex inter-
pretation, for example Doppler ultrasound for fetal blood flow and computer-
ized analysis of fetal heart rate changes. However, even with these modalities of
fetal assessment to determine the optimal timing of delivery, fetal movements
remain integral to clinical decision-making. In high-risk cohorts with fetal
growth restriction, the manifestation of a reduction in perceived movements
may warrant an expedited delivery. Despite this, there has been little evolution
in the development of technologies to objectively evaluate fetal movement
behavior for clinical application. This review explores the available literature on
the value of fetal movement analysis as a method of assessing fetal wellbeing,
and demonstrates how interdisciplinary developments in this area may aid in
the improvement of clinical outcomes.
Abbreviations: BPP, biophysical profile; cCTG, computerized cardiotocograph;
CTG, cardiotocograph; FGR, fetal growth restriction; FHRV, fetal heart rate
variability; SGA, small for gestational age; STV, short-term variation.
Introduction
The obstetrician’s role in the antenatal period is princi-
pally early detection and management of maternal and
fetal conditions that may influence the pregnancy out-
come. In the third trimester, the main objective is to
reduce the risk of stillbirth. Although some stillbirths are
related to chromosomal or structural abnormalities,
which may carry a poor prognosis irrespective of the tim-
ing of delivery, other pathologies may benefit from early
detection.
In a large population-based cohort study of 2675 still-
births from 1997 to 2003, 43% were attributable to fetal
growth restriction (FGR) (1). If detected, a diagnosis of
FGR may influence care and reduce the risk of stillbirth.
In the past, FGR and small for gestational age (SGA) were
Key Message
The association between normal fetal movements and
the physiological state in utero is clear. Its correlation
with reassuring and pathological features of existing
monitoring techniques support its clinical use, but
this is dependent upon establishment of an accurate
and objective assessment tool.
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terms used almost interchangeably. Recently, there is an
emerging concept that FGR may be diagnosed in a fetus
whose biometry is within the normal percentiles, but
where there is reduced growth velocity. This is a further
challenge in the identification of FGR, and one that will
require new screening strategies that do not rely on fetal
biometry alone. Although fetal monitoring modalities
have developed to help optimize the timing of delivery,
perceived fetal movements remain crucial in that clinical
decision-making.
Hypoxia
Adequate oxygenation of the fetal tissues is central to fetal
wellbeing. The importance of fetal movements as a mar-
ker of health has been demonstrated in sheep models,
with fetal behavior being reflective of fetal brain function.
In acute onset hypoxemic intrauterine environments,
movements are significantly reduced as a mechanism
to conserve energy consumption (2). However, with
prolonged stable hypoxemic exposure, fetal movements
can return to normal patterns, presumably as part of
a compensatory mechanism until the fetus becomes
acidemic (3).
Physiology of fetal growth restriction
The physiological adaptations of the fetus during periods
of hypoxemia are characterized by redistribution of blood
flow away from the peripheries to the brain, heart and
adrenals. Prolonged under-perfusion of the peripheral
and hepato-enteric circulation results in tissue hypoxia
and the accumulation of lactic acid, resulting in fetal aci-
dosis. In the setting of placental insufficiency, acidemia is
exacerbated by the reduced clearance of carbon dioxide.
This brain-sparing response has been shown to affect fetal
growth, Doppler blood flow and heart rate variability as
well as fetal behavior. Understanding these physiological
changes has facilitated the development of fetal monitor-
ing techniques which aim to detect acute-on-chronic fetal
compromise, and so to time delivery appropriately.
Our understanding of “at risk” babies is mainly derived
from the monitoring of severely growth restricted fetuses.
To understand the physiology of those at risk within the
normal percentile range, it is important to appreciate
fully the mechanisms involved in these severely compro-
mised fetuses. Management of severe growth restriction is
a delicate balance between the risks of iatrogenic preterm
delivery and prolonging intrauterine maturity, with the
risks of stillbirth and chronic acidemia to the fetus. In
Europe, timing of delivery is largely based on Doppler
investigations and fetal heart tracing, which identify
hemodynamic decompensation and acidemia, respectively
(4). However, in the USA, management is guided by the
biophysical profile (BPP), a composite measure of the
ultrasound assessment of amniotic fluid volume, fetal
tone, breathing and movement, and fetal heart rate
assessment (5). There is evidence that a reduction in fetal
breathing and amniotic fluid volume resulting in an
abnormal BPP score, is a late change that follows arterial
and venous Doppler derangement (6). As such, its use
may have a role in prolonging intrauterine maturity.
While biophysical scoring is a composite measurement of
physiological function, individual components of fetal
movement have also been associated with fetal wellbeing.
Movement patterns
Fetal movement patterns are determined by neurological
development of the fetus and its metabolic state. Early
studies have shown that behavioral states of the normal
fetus change throughout gestation, with periods of quies-
cence ranging on average from six minutes in the second
trimester, up to 37 min in the late third (7). It has been
suggested that the reduction in movements is due to
improved coordination due to neurological maturity, in
addition to reduced amniotic fluid and intrauterine space
(8). Movement patterns also alter diurnally, with demon-
strably increased fetal activity during the evening com-
pared with that during the day (9).
Fetal movements and outcome
Numerous studies have shown that fetal movement pro-
vides an important measure of fetal health. Of women
perceiving decreased fetal movements, 25% have poor
perinatal outcomes, and more than half of stillbirths are
preceded by decreased fetal movements (10). However,
within a low-risk population, the detection rate of
growth-restricted fetuses in response to a reduced percep-
tion of fetal movements, remains low. Although this may
reflect the inter-patient subjectivity of quantifying move-
ments, the correlation of perception and concurrent
“true” movements detected by ultrasound is at best mod-
est, with concordance as low as 37%, and false-positive
rates of up to 30% (11). Moreover, in keeping with the
data seen with biophysical profiling, a perceived reduction
of movements is often a late sign which can already sig-
nify irreversible fetal compromise (12).
Currently, the only practical modality of quantifying
fetal movements is through maternal perception. There is
no consensus regarding the clinically significant lower
threshold of movements; accordingly, the Royal College
of Obstetricians and Gynaecologists does not recommend
the quantification of movement through the use of kick
charts (13).
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When we consider the evidence from both animal and
human studies, it is clear that fetal movement patterns
are still not well defined. While a reduction in move-
ments may represent an acute hypoxic episode, the
restoration of movements may represent either a resolu-
tion of the hypoxia or the onset of a stable, chronic
hypoxia. This is of critical importance in the management
of antenatal patients: are we currently being falsely reas-
sured by the return of movements? Moreover, would lon-
gitudinal quantification of these movements aid in
reducing stillbirths? Currently, the only practice sup-
ported by strong evidence for screening of FGR is fetal
biometry and Doppler studies (14). However, although
this allows detection of those babies which are SGA, i.e. a
size less than the 5th or the 10th percentile, the majority
of term stillbirths are within the normal weight per-
centiles (15). This poses an important dilemma that there
is currently no strategy to tackle: how do we determine
“at risk” fetuses that are not meeting their growth poten-
tial but who lie within two standard deviations of the
mean? These are truly growth-restricted fetuses that are
failing to meet their growth potential secondary to a
pathological process, as opposed to being simply SGA.
Arguably, the former is the cohort that is most at risk.
This cohort of patients may be falsely reassured follow-
ing an ultrasound scan with conventional parameters.
The capability to objectively characterize movement
patterns may aid our understanding of normality and
allow detection of fetuses at risk, who can then be offered
further antenatal surveillance and organization of a timely
delivery.
Existing methods for assessing fetal
health
Cardiotocography (CTG)
Cardiotocography is a well-established method of moni-
toring fetal wellbeing. Its underlying principle is that
compensatory changes of heart rate patterns can be pre-
dictive of fetal hypoxia. Four features are typically
described in the interpretation of a CTG trace; each of
these will be discussed below in terms of their relation to
fetal wellbeing.
Fetal heart rate variability (FHRV). Antenatal elec-
tronic fetal monitoring of FHRV is an important predic-
tor of fetal wellbeing in SGA pregnancies (16). Profound
reductions in FHRV are thought to represent acute fetal
compromise. Unlike clinical assessment of FHRV on a
traditional CTG, which has well acknowledged intra-
observer variability and which does not alter perinatal
mortality (17), computerized CTG (cCTG) produces
objective measures of FHRV based on the Dawes–Red-
man criteria previously published (18). One such mea-
sure, short-term variation (STV), is a statistical summary
measure of the variation in inter-beat intervals of a 3.75-s
epoch of averaged fetal heart rate recordings, excluding
pronounced accelerations and decelerations. Reduction of
STV to below 3 ms within 24 h of delivery has been
shown to be predictive of an increased risk of metabolic
acidosis and early neonatal death (16). Although there is
a clear correlation between fetal acidosis and a reduction
in fetal movements (19), the use of movement as an
objective measure for detecting acidosis has not been
translated into clinical use. As such, interpretation of
cCTG based on STV remains essential for prenatal
surveillance of fetuses with suspected FGR to detect acute
fetal distress requiring delivery (14). STV is recognized to
be lower in FGR fetuses than in control groups, even
while remaining above the critical threshold of 3 ms, with
a positive predictive value for acidemia of 77% (20);
attempts to better predict fetal acidemia outside the con-
text of acute fetal distress are being made by further
cCTG characterization of the accelerative capacity of the
fetal heart rate (20,21).
Baseline fetal heart rate. The baseline fetal heart rate
fluctuates under the influence of centrally mediated sym-
pathetic and parasympathetic tones. The rate can alter with
increasing gestational age as these two systems mature at
different rates and between different fetal behavioral states
(22). Diurnal variation in FHRV is also seen, as well as a
certain amount of intrinsic variability (23). Increases in
normal values for STV are seen with advancing gestational
age with lower rates of increase in FGR fetuses (21). Ultra-
sound CTG studies (24) and fetal magnetocardiogram
studies (25) demonstrate that the relative time spent in
each fetal behavioral state is unchanged between normally
grown and growth-restricted fetuses. This suggests that
autonomic dysregulation of FHR control, even when not
acutely distressed, underlies the observed differences in
FHR variation between these groups. Whether this repre-
sents a loss of autonomic control or an inability of the fetal
heart to respond to autonomic control has yet to be
demonstrated.
Accelerations. Fetal heart accelerations are an indica-
tion of normal neurological function, mediated through
the somatic nervous system. In a study investigating the
association of accelerations with fetal movements, 52
fetuses under CTG surveillance were simultaneously
scanned by ultrasound. The study demonstrated that
99.6% of large accelerations and 82.4% of small accelera-
tions were associated with concurrent fetal movements
(26). Conversely, the absence of accelerations has been
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noted during fetal sleep cycles. This physiological phe-
nomenon may reflect the parasympathetic dominance
during periods of rest.
Decelerations. Late decelerations are typically associ-
ated with fetal distress. Schifrin et al. demonstrated with
the use of concurrent real time ultrasonography that late
decelerations occurring following a normal CTG trace
with a stable baseline and variability may be strongly sug-
gestive of fetal breathing movements (27). Fetal breathing
is an important component of biophysical profiling and
is typically associated with fetal wellbeing (5). The find-
ings support previous observations that isolated decelera-
tions with a normal baseline and variability are not
usually associated with an adverse outcome (28).
Doppler ultrasonography
Doppler ultrasound provides valuable information on the
impedance to blood flow through vessels. In the setting
of placental insufficiency and FGR, changes are first seen
in the umbilical artery that is reflective of high placental
impedance. However, this typically only manifests after
30% of the placenta is affected (29). As a compensatory
mechanism, blood is preferentially redirected to the brain
that is reflected in lower impedance to flow in the middle
cerebral arteries. Late changes are reflected in the venous
system as demonstrated by changes in flow velocity pat-
tern of the ductus venosus. Its compromise (demon-
strated by “a” wave reversal) reflects altered cardiac
function as a result of altered shunting of oxygenated
blood from the umbilical vein into the fetal heart, and is
predictive of poor prognosis.
The understanding of the sequence of Doppler changes
reflecting hemodynamic compensation in early growth-
restricted fetuses has gradually evolved to improve neona-
tal outcome (30). However, management strategies to
prolong intrauterine maturity of late FGR are less clear,
in part because sub-critical failure of placental function
may not result in Doppler changes or severe growth
restriction.
Biophysical profile
Investigators have previously correlated Doppler changes
with BPP to improve surveillance for high-risk babies
(31). In a large cohort of 987 patients, Crimmins et al.
found that all biophysical parameters became abnormal
in severely growth-restricted fetuses at <34 weeks’ gesta-
tion, with hemodynamic redistribution and changes in
venous Dopplers. In the less severe group involving
patients at >34 weeks’ gestation, but also exhibiting cere-
brovascular redistribution on Doppler, they demonstrated
that BPP changes were generally a late feature, with nor-
mal findings still seen within a week of stillbirth. These
results suggest that the biophysical parameters that were
assessed in this high-risk cohort may have been such a
late feature that they were not clinically useful in the pre-
vention of stillbirth. This supports the use of current
management strategies based on Doppler techniques as
the most predictive of adverse outcome.
However, complex Doppler investigations are typically
only performed in specialized units and once FGR is sus-
pected. Bardakci et al. compared the performance of the
umbilical artery Doppler with a modified BPP score in
fetuses at >36 weeks’ gestation (32). The data suggest that
the detection of adverse perinatal outcomes was superior
with BPP compared with umbilical artery Doppler. This
either suggests that more comprehensive Dopplers than
just those of the umbilical artery are essential for surveil-
lance of late fetal distress, or that the sensitivity of the
BPP may be improved with gestational maturity.
Assessment of fetal movements
Maternal sensation
Despite the development of ultrasound scanning and
Doppler technologies, maternal perception remains the
most common method of quantifying movement as a
marker of fetal health. Reduced movements have been
associated with poor outcome in terms of growth restric-
tion and stillbirth, with the UK Confidential Enquiry into
Stillbirths and Deaths in Infancy indicating that 16% of
all stillbirths are preceded by a reduction of perceived
activity (33). When the outcome measures are broadened
to consider neonatal outcomes such as intrauterine
growth restriction in addition to stillbirths, the incidence
of reduced fetal movements is found to be even greater,
experienced by 25% of those who subsequently delivered
with an adverse outcome (10).
Unfortunately, our comprehension of fetal movement
patterns still does not provide clear guidance on the
quantification of perceived movements which can be clas-
sified as “normal” or “safe”. In fact, the advice of a mini-
mum threshold of 10 fetal movements per 12-h period
that often forms the basis for counseling patients, origi-
nated from data involving high-risk populations who
were studied as inpatients on wards (34). This is prob-
lematic both in itself, being based on a skewed popula-
tion, and also due to the confounding effects of
psychological impact while a hospital inpatient. Despite
the lack of consensus in clinical guidelines, “kick count-
ing” has been established as a common method of screen-
ing high-risk patients in many healthcare settings.
However, in a major study involving 68 000 women
ª 2016 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd
on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)., 95 (2016) 968–975
971
J. Lai et al. Fetal movements
randomized to counting or not, no significant difference
in outcomes for the two groups were observed. The
authors concluded that once perceived movements were
reduced, it was often too late to save the baby (35).
Cardiotocograph
Rayburn et al. investigated overall CTG interpretation in
comparison with perceived fetal movements quantified by
the mother (36). In 206 high-risk individuals, they found
that 97% of women with an active fetus had normal CTG
parameters. Moreover, in the presence of reduced fetal
movement with an abnormal CTG, the outcomes were
invariably poor. However, in larger populations where
CTG is used in the setting of triaging women who pre-
sent with reduced movements, Valentin et al. report a
poor concordance between perceived movements and
abnormal CTG findings; with 84% found to have reassur-
ing CTGs (12). Although it is not clear from the data
whether the sequence of natural events are reduced move-
ments prior to heart rate changes, or vice versa, their use
in conjunction has a good sensitivity when both are
abnormal.
Actograph
Due to the significant time involved with performing
movement characterization using ultrasound, there have
been efforts to find alternative tools to analyze fetal
movements. During the 1980s, an actograph function was
introduced to fetal heart rate monitoring by CTG. The
actograph separates high-frequency Doppler signals,
indicative of the fetal heart rate, from low-frequency sig-
nals, indicative of fetal movements. A number of early
studies showed promising results of capturing major fetal
movements, reporting a concordance of movements with
concurrent real time ultrasonography of as high as 95%
(37,38). However, in later studies, as actograph became
more widely available and was incorporated into most
CTG devices, it was reported that false-positive rates were
unacceptably high and the authors urged caution in its
clinical use (39). Currently, the actograph is not widely
used in either clinical or research settings.
Ultrasound and BPP
Given that Manning first proposed the BPP as an impor-
tant technique in the assessment of wellbeing in 1979, it
is surprising that technology to objectively quantitate and
potentially qualitatively analyze different types of move-
ment in relation to fetal health has not progressed as
quickly as other modalities of fetal monitoring. Ultra-
sound remains the gold standard in total quantification,
and although numerous groups have comprehensively
characterized fetal movement patterns (40,41), the most
common clinical application of using movement as a
component of antenatal surveillance remains the BPP or
a modified variant.
The BPP describes five parameters which reflect nor-
mal function and perfusion to different organ systems;
the underlying principle that hypoxia to any of those sys-
tems can be detected on scan and heart rate tracing, with
a composite score to reflect overall fetal wellbeing [5].
Nageotte et al. compared the performance of BPP with a
contraction stress test, an assessment performed to assess
a CTG response to an iatrogenically induced uterine con-
traction, where a negative result was predictive of
tolerance to labor. In their high-risk series, no significant
difference was observed between the perinatal outcomes
for those with a negative BPP from those with a negative
contraction stress test (42). Although it is clear even
from the early work that this ultrasound-based assess-
ment has value in antenatal surveillance, its utilization
has certainly been limited within Europe due to its nega-
tive performance as compared with fetal heart monitor-
ing (43). As both CTG and BPP changes are reflective of
neuroendocrine and neurophysiological responses to
hypoxic stress, their similarity in performance seems
plausible.
New technologies
Other approaches that have been trialed for fetal move-
ment monitoring include magnetocardiograph recordings
(a non-invasive technique in which changes in the mag-
netic field near the maternal abdomen due to the electri-
cal activity of the fetal heart are acquired and interpreted)
(44) and multi-Doppler sensor systems (45). However,
neither of these techniques have been compared with
concurrent ultrasound or maternal sensation.
More recently, the utilization of MRI in fetal medicine
has aided the development of cine MRI. This technique
allows accurate assessment of global fetal movements
(46), even in late gestation, that may otherwise be limited
with ultrasound. However, its use is limited to the
research arena due to the resources needed, as well as the
time-intensive post-capture analysis required.
Some studies have explored fetal movement monitors
for maternal wear (47–50), but none of these systems is
in routine clinical use. A number of studies have investi-
gated the potential of measuring vibrations transmitted
through the maternal abdomen as a predictor of fetal
movements. Such systems have the advantages of being
non-transmitting, usable in a home setting, and poten-
tially low in cost. Mesbah et al. developed a fetal activity
monitor based on accelerometers, being the first to
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introduce a method to account for maternal movement
artifact as a technique to improve specificity (47).
Although their overall sensitivity was good at 76%
when compared with real time ultrasonography, their
specificity remained low at 56%. A similar study from
Girier et al. (48), also involving an accelerometer-based
system, reported a true detection rate of 62% and an
average false detection rate of 40%, concluding that
only large fetal movements are registered by an
accelerometer system and that accelerometers are prone
to signal artifacts due to maternal movement. Two
groups have proposed fetal movement monitors based
on capacitive acceleration sensors to detect oscillations
of the maternal abdomen (49,50). Nishihara et al. (49)
reported an 87.7% agreement between subjective mater-
nal sensation and their sensor. Although using similar
technology, Ryo et al. reported that their sensors were
most effective in picking up gross fetal movements
(with prevalence- adjusted bias-adjusted kappa values
ranging between 0.69 and 0.83), but less effective in
detecting breathing or isolated limb movements com-
pared with ultrasound.
It is clear that all passive forms of fetal monitoring
that record the physical signals of the fetus through the
maternal abdomen are inferior to the gold standard of
ultrasound. However, methods such as accelerometry or
phonography have the advantage of capturing auto-
mated, longitudinal data in the out-of-hospital setting
where it is most needed, even if they systematically
under-recorded. These methods to record movement sig-
nals will only be optimized by the use of multiple sen-
sors over the maternal abdomen in order to maximize
the likelihood that movement is registered. However, the
disadvantage of this is that undesirable artifacts that are
not fetal in origin will naturally increase. How sensitive
the signals are and the manner in they are processed is a
key element in the performance of these types of devices,
and accuracy levels can vary significantly between analy-
sis techniques and sensing modality. Astute strategies to
tackle this problem include the introduction of a refer-
ence sensor to identify and remove maternal movement
artifacts. Complex signal processing and development of
intricate algorithms will determine the successes of these
devices in clinical practice. It is unrealistic to expect any
one algorithm to provide a high yield in accurate detec-
tion of all movements; a compromise will have to be
made between accuracy and the type of movement
behaviors useful to discern.
Longitudinal, prospectively collected data from such
devices could finally allow clinicians and researchers to
reach a consensus on normal fetal movement patterns
according to gestational age, and whether these will
translate into a useful tool in our management of babies
at risk of stillbirth.
Conclusion
Treatment options available in the field of fetal medicine
are limited. The most important fundamental strategy to
improve fetal health is determining the optimal time for
delivery. The importance of such an approach is essential,
especially for growth-restricted fetuses. The ability to
detect and appropriately time delivery will determine
whether a mother will take home a healthy but poten-
tially iatrogenically premature baby, one with residual
effects of chronic hypoxic starvation or, worse, be faced
with delivery of a stillborn. It is clear that our manage-
ment strategies have developed over the past 30 years,
and although the indications for delivery have very
recently been clearly defined in the small population of
growth-restricted fetuses <32 weeks’ gestation (30), the
strategies for later gestations, where the burden of still-
birth is greater, is less clear. Moreover, even within this
cohort, the detection is still reliant on direction from
mothers reporting reduced fetal movements. The difficul-
ties for this “late” group lie not only in consensus regard-
ing the most appropriate monitoring techniques, but
perhaps more importantly in identifying our target popu-
lation, given that the babies most at risk, lie within the
normal growth percentiles.
The evidence presented advocates that fetal movements
have an important role in antenatal surveillance, but we
are currently lacking the technology to utilize this impor-
tant marker of wellbeing. There is an urgent need for new
technologies, or better application of existing ones, to
objectively assess fetal movements in the low-risk setting
and to characterize how these may relate to fetal health.
In doing so, it may become possible for us to improve
management of FGR, more precisely determine optimal
delivery timing and potentially reduce stillbirths.
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